SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
27-Aug-24 5:58 PM View: | Neumora Therapeutics, Inc. (NMRA) | 27-Aug-24 | Sale (Planned) | 15,693 | $11.39 | $178,806.00 | (7%) 239.66K to 223.97K | |
26-Aug-24 6:17 PM View: | Neumora Therapeutics, Inc. (NMRA) | 26-Aug-24 | Sale (Planned) | 31,642 | $11.78 | $372,588.00 | (12%) 271.3K to 239.66K | |
26-Aug-24 6:17 PM View: | Neumora Therapeutics, Inc. (NMRA) | 23-Aug-24 | Sale (Planned) | 24,169 | $11.59 | $280,005.00 | (8%) 295.47K to 271.3K | |
26-Aug-24 6:17 PM View: | Neumora Therapeutics, Inc. (NMRA) | 22-Aug-24 | Sale (Planned) | 28,496 | $11.63 | $331,468.00 | (9%) 323.96K to 295.47K | |
28-Jun-24 9:00 PM View: | Neumora Therapeutics, Inc. (NMRA) | 17-Apr-24 | Gift | 238,965 | -- | -- | (42%) 562.93K to 323.96K | |
16-Feb-24 4:21 PM View: | Neumora Therapeutics, Inc. (NMRA) | 14-Feb-24 | Grant | 85,000 | -- | -- | 36% 238.97K to 323.96K |